SANUWAVE Health (OTCMKTS:SNWV) and Arch Therapeutics (OTCMKTS:ARTH) Critical Review
Critical Comparison: Arch Therapeutics (OTCMKTS:ARTH) vs. Biostage (OTCMKTS:BSTG)
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)
Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?
7 Stock Winners That Are Up 1,000% or More in 2023
Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?
Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?
Arch Therapeutics Provides Year End Operational Update
Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
Arch Therapeutics Provides AC5® Commercialization Update
Arch Therapeutics Completes Financing as Bridge to Uplisting
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)
Arch Therapeutics Accepted to Present AC5® Advanced Wound System During Innovation Spotlight at 2022 Symposium on Advanced Wound Care (SAWC)
Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) Fall
Arch Therapeutics Launches Experts in Wound Care Program
Arch Therapeutics Provides Corporate Update
Arch Therapeutics to Present at the LD Micro Main Event
Arch Therapeutics Launches Coverage and Reimbursement Pilot
Arch Therapeutics Announces Appointment of Larry Hicks to the Board
Arch Therapeutics Completes Leadership Team with Appointment of Dan Yrigoyen as Vice President of Sales
Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 2021
Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 - 10, 2021
Arch Therapeutics Appoints Michael S. Abrams its Chief Financial Officer
Arch Therapeutics to Present AC5® Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC)
Arch Therapeutics Provides Corporate Update on Commercialization Efforts and Clinical Results
Arch Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference, March 9-10, 2021
Arch Therapeutics Announces Closing of $6.9 Million Private Placement
Arch Therapeutics Announces $6.9 Million Private Placement
Arch Therapeutics to Present at the H.C. Wainwright BioConnect Conference, January 11 - 14, 2021
Arch Therapeutics Announces Distribution Agreement with Buffalo Supply, Inc.
Arch Therapeutics to Present at the 13th Annual LD Micro Main Event Conference
Arch Raises Approximately $1.1 Million with Convertible Note Issuance
Arch Therapeutics' AC5 Advanced Wound System Presented at the 2020 Symposium on Advanced Wound Care (SAWC) Fall